DanaherDHR
DHR
About: In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
Employees: 63,000
0
Funds holding %
of 7,139 funds
0
Analysts bullish %
of 8 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
76% more call options, than puts
Call options by funds: $1.78B | Put options by funds: $1.01B
17% more first-time investments, than exits
New positions opened: 223 | Existing positions closed: 190
0.15% more ownership
Funds ownership: 78.53% [Q3] → 78.68% (+0.15%) [Q4]
3% less funds holding
Funds holding: 2,235 [Q3] → 2,178 (-57) [Q4]
17% less capital invested
Capital invested by funds: $160B [Q3] → $132B (-$27.4B) [Q4]
18% less repeat investments, than reductions
Existing positions increased: 743 | Existing positions reduced: 910
42% less funds holding in top 10
Funds holding in top 10: 97 [Q3] → 56 (-41) [Q4]
Research analyst outlook
8 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$240
14%
upside
Avg. target
$262
25%
upside
High target
$290
38%
upside
8 analyst ratings
5 positive
63%
3 neutral
38%
0 negative
0%
Citigroup Patrick Donnelly 33% 1-year accuracy 10 / 30 met price target | 26%upside $265 | Buy Maintained | 30 Jan 2025 |
RBC Capital Conor McNamara 5% 1-year accuracy 2 / 37 met price target | 32%upside $277 | Outperform Reiterated | 30 Jan 2025 |
Baird Catherine Schulte 10% 1-year accuracy 2 / 20 met price target | 23%upside $258 | Outperform Maintained | 30 Jan 2025 |
Wells Fargo Brandon Couillard 14% 1-year accuracy 3 / 22 met price target | 14%upside $240 | Equal-Weight Maintained | 30 Jan 2025 |
Barclays Luke Sergott 31% 1-year accuracy 16 / 52 met price target | 14%upside $240 | Equal-Weight Maintained | 30 Jan 2025 |
Financial journalist opinion
Based on 15 articles about DHR published over the past 30 days
Neutral
PRNewsWire
1 day ago
Danaher Announces Appointment of Charles Lamanna to Danaher Board
WASHINGTON , Feb. 20, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it has appointed Charles Lamanna to its Board of Directors and to the Board's Science & Technology Committee. Mr. Lamanna is currently Corporate Vice President, Business & Industry Copilot at Microsoft (NASDAQ: MSFT), where he drives product innovation in AI-powered business applications, low-code platforms, and autonomous agents.
Neutral
PRNewsWire
1 day ago
Danaher Increases Quarterly Dividend
WASHINGTON , Feb. 20, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on April 25, 2025 to holders of record on March 28, 2025. This reflects an 18.5% increase over the previous dividend payment of $0.27.
Positive
Seeking Alpha
5 days ago
Danaher: Self-Inflicted Pessimism?
Danaher Corp. has faced market punishment recently, but maintains strong margins and impressive FCF despite a tough year, indicating resilience and potential for future growth. The company's strategic capital allocation, including share buybacks and acquisitions, suggests management is positioning for long-term value creation, despite short-term pessimism. Danaher's bioprocessing segment shows consistent growth, and the upcoming patent cliff is expected to provide significant tailwinds, boosting demand for their life science equipment.
Positive
Seeking Alpha
1 week ago
All-In: The 23-Stock Six-Figure Dividend Portfolio I'm Betting My Future On
Thank you to the Seeking Alpha community for your support! Reaching 40,000 followers is a dream come true. Your feedback fuels my work. I've invested 91% of my net worth in 23 high-conviction dividend stocks. Focused on wide-moat businesses, I prioritize quality and long-term growth over yield. My portfolio has outperformed the S&P 500, and I'm confident in its future. I expect a rotation to value stocks, and I'll keep sharing insights to grow together.
Positive
Morningstar
1 week ago
3 Top Value Stocks to Buy and Hold for 2025
These high-quality companies are solid—and their stocks look cheap.
Positive
Seeking Alpha
1 week ago
Where I'd Put $10,000 Right Now - My Best Dividend Picks For Income And Growth
I started investing with a modest $4,000, now growing it into a 23-stock portfolio. The median net worth varies by age, but most can invest $10,000 for growth. The goal here isn't to push random picks, but to offer long-term dividend ideas. I connect my choices to the broader economic picture, from undervalued essentials to GARP stocks. In this article, I highlight undervalued consumer staples, GARP stocks, and investment ideas linked to potential political changes, all aimed at steady dividend growth.
Negative
Benzinga
3 weeks ago
Danaher Analysts Cut Their Forecasts After Downbeat Earnings
Danaher Corporation DHR reported weaker-than-expected fourth-quarter earnings on Wednesday.
Neutral
Zacks Investment Research
3 weeks ago
Danaher Q4 Earnings Miss Estimates, Life Sciences Sales Rise Y/Y
DHR's fourth-quarter sales increase 2.1% year over year, benefiting from the solid performance of its Life Sciences and Biotechnology segments.
Positive
Zacks Investment Research
3 weeks ago
Danaher (DHR) Reports Q4 Earnings: What Key Metrics Have to Say
The headline numbers for Danaher (DHR) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Neutral
Seeking Alpha
3 weeks ago
Danaher Corporation (DHR) Q4 2024 Earnings Call Transcript
Danaher Corporation (DHR) Q4 2024 Earnings Call Transcript
Charts implemented using Lightweight Charts™